You have 9 free searches left this month | for more free features.

Lymphohistiocytosis, Hemophagocytic

Showing 1 - 25 of 131

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma-associated Hemophagocytic Lymphohistiocytosis

Recruiting
  • Lymphoma
  • Hemophagocytic Lymphohistiocytoses
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 1, 2023

    Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

    Not yet recruiting
    • Refractory
    • +2 more
    • GTP regimen
    • (no location specified)
    Sep 8, 2023

    EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

    Recruiting
    • EBV-associated Hemophagocytic Lymphohistiocytosis
    • EBV Infection
    • EBV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 12, 2023

    IFN? and Inflammatory Mediators in Hemophagocytic

    Completed
    • Hemophagocytic Lymphohistiocytoses
    • Blood Draws Data Collection
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Sep 14, 2023

    Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

    Not yet recruiting
    • Carbapenem Resistant Bacterial Infection
    • Hemophagocytic Lymphohistiocytoses
    • Carrimycin tablets
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Aug 4, 2023

    Hemophagocytic Lymphohistiocytoses Trial in Cincinnati

    Recruiting
    • Hemophagocytic Lymphohistiocytoses
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Oct 25, 2022

      PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

      Not yet recruiting
      • PD-1 Antibody
      • +3 more
      • L-DEP and PD-1 antibody
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Mar 8, 2023

      Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

      Recruiting
      • Secondary Hemophagocytic Lymphohistiocytosis
      • Chronic Active Epstein-Barr Virus Infection
      • No intervention
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      May 2, 2023

      Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

      Recruiting
      • Hemophagocytic Lymphohistiocytosis
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Sep 15, 2022

      Segmental Resection Combined With DEP Regimen for EBV-HLH

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytosis
      • +2 more
      • Segmental bowel resection combined with the DEP regimen
      • Beijing, Beijing, China
        Zhao Wang
      Nov 9, 2023

      Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

      Not yet recruiting
      • Haemophagocytic Lymphohistiocytosis
      • (no location specified)
      Feb 28, 2023

      Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytoses
      • +2 more
      • observational
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Dec 22, 2022

      Assessing the Presence of CT-DNA in Lymphoma Associated HLH

      Not yet recruiting
      • Lymphoma
      • Haemophagocytic Lymphohistiocytosis
        • (no location specified)
        Jan 25, 2023

        Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytoses
        • Lymphoma
        • cytokine
        • Beijing, Beijing, China
          Zhao Wang
        Oct 27, 2022

        Prospective Validation of the OHI Index

        Recruiting
        • HLH
        • +4 more
          • Kfar Saba, Israel
          • +1 more
          May 21, 2023

          Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

          Recruiting
          • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
          • Innsbruck, Austria
          • +9 more
          Oct 24, 2022

          Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

          Withdrawn
          • Hemophagocytic Lymphohistiocytosis
          • Philadelphia, Pennsylvania
            Children's Hospital of Philadelphia
          Mar 11, 2022

          Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

          Recruiting
          • Secondary Hemophagocytic Lymphohistiocytosis
          • Chronic Active Epstein-Barr Virus Infection
          • Rituximab Monotherapy
          • Beijing, China
            Zhao Wang
          May 18, 2022

          Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

          Not yet recruiting
          • Hemophagocytic Lymphohistiocytosis
          • L-DEP and PD-1 antibody
          • Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Apr 19, 2022

          Hemophagocytic Syndrome Trial in Chongqing (cyclophosphamide, VP-16, Dexamethasone)

          Recruiting
          • Hemophagocytic Syndrome
          • Chongqing, China
            The Second affiliated Hosptial of Chongqing medical University
          Jun 28, 2023

          Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)

          Recruiting
          • Hemophagocytic Lymphohistiocytosis
          • DEP combine with PD-1 antibody
          • Beijing, China
            Beijing Friendship Hospital, Capital Medical University
          Feb 13, 2022

          Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

          Recruiting
          • Hemophagocytic Lymphohistiocytosis
          • Phoenix, Arizona
          • +9 more
          Jan 9, 2023

          Toxicities in Children and Adults With Cancer

          Active, not recruiting
          • Macrophage Activation Syndrome
          • Primary Hemophagocytic Lymphohistiocytosis
            • Bethesda, Maryland
              National Cancer Institute (NCI)
            Sep 17, 2022

            Primary Hemophagocytic Lymphohistiocytosis Trial in China (Emapalumab-Lzsg 5 MG/ML [Gamifant])

            Recruiting
            • Primary Hemophagocytic Lymphohistiocytosis
            • Emapalumab-Lzsg 5 MG/ML [Gamifant]
            • Shanghai, Fudan, China
            • +6 more
            Feb 23, 2023

            Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

            Active, not recruiting
            • Leukemia
            • Houston, Texas
              University of Texas MD Anderson Cancer Center
            Feb 2, 2022